Literature DB >> 12023575

New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas.

Yih-Leong Chang1, Chen-Tu Wu, Jin-Yuan Shih, Yung-Chie Lee.   

Abstract

Lymphoepithelioma-like carcinoma, an uncommon epithelial tumor, has been described as being closely associated with Epstein-Barr virus (EBV) infection in many organs, especially the nasopharynx. We experienced 23 cases of lymphoepithelioma-like carcinoma arising in the lung from 2498 lung cancer patients in the Cancer Registry of our hospital. Seven patients were male and 16 were female. All patients were Chinese. Their ages ranged from 42 to 80 years. Six patients were smokers and 17 were nonsmokers. The tumor sizes ranged from 1.2 to 11.0 cm. All tumors showed the typical syncytial growth pattern of undifferentiated epithelial cells with a significant CD8+ T-lymphocyte reaction. EBV serology revealed prior infection in all 15 serum-available patients, all of whom were also found by in situ hybridization to have the virus genome. In addition, the higher the EBV serology titer, the larger the tumor size and the higher the staging would be. EBV viral capsid antigen IgG level remained elevated despite response to therapy. Nearly all cases had bcl-2 oncoprotein expression, but the detection rate of latent membrane protein-1, p53, and c-erb B-2 expression was extremely low. The encouraging chemotherapy response for advanced stage disease is also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023575     DOI: 10.1097/00000478-200206000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  28 in total

1.  Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature.

Authors:  Chul Kim; Arun Rajan; Pedro A DeBrito; Giuseppe Giaccone
Journal:  Transl Lung Cancer Res       Date:  2016-12

2.  Primary lymphoepithelioma-like carcinoma of the lung: An unusual cancer and clinical outcomes of 14 patients.

Authors:  Lan Lin; Tingyan Lin; Bangwei Zeng
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

3.  Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.

Authors:  H H Ishii; G C Gobe; J Yoneyama; M Mukaide; Y Ebihara
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

4.  Primary Pulmonary Lymphoepithelioma-like Carcinoma on FDG PET/CT.

Authors:  Gul Ege Aktas; Nuray Can; Selin Soyluoglu Demir; Ali Sarıkaya
Journal:  Nucl Med Mol Imaging       Date:  2016-06-11

5.  Advanced primary pulmonary lymphoepithelioma-like carcinoma: clinical manifestations, treatment, and outcome.

Authors:  Chun-Yu Lin; Ying-Jen Chen; Meng-Heng Hsieh; Chih-Wei Wang; Yueh-Fu Fang
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

Review 6.  Primary pulmonary lymphoepithelioma-like carcinoma.

Authors:  Ying Fan; Chenghui Li; Jing Qin; Hongyang Lu
Journal:  Med Oncol       Date:  2020-03-07       Impact factor: 3.064

7.  Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung.

Authors:  Qianwen Liu; Guowei Ma; Haoxian Yang; Jing Wen; Mei Li; Hong Yang; Kongjia Luo; Yi Hu; Jianhua Fu
Journal:  Thorac Cancer       Date:  2014-01-02       Impact factor: 3.500

8.  Epstein-Barr virus associated lymphoepithelial carcinoma of the esophagus.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Med       Date:  2013-03-21

9.  Primary lymphoepithelioma-like carcinoma of the esophagus with metastatic lymph node and gastric cancer.

Authors:  Kosuke Narumiya; Yosuke Yagawa; Kenji Kudo; Shinsuke Maeda; Yukinori Toyoshima; Kyohei Ogawa; Sho Izumika; Kimito Harada; Masayuki Itabashi; Harushi Osugi
Journal:  Clin J Gastroenterol       Date:  2021-07-30

Review 10.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.